Skip to content
naulon

Not checkedNot checked for notices yet.

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma

Zeng Mu-Sheng, Guan Xin-Yuan, Deng Hai-Xia and 7 more

BMC Cancer · 2010

doi:10.1186/1471-2407-10-133 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>It has been suggested that the B-cell specific moloney leukemia virus insertion site 1 (Bmi-1) gene plays an oncogenic role in several types of human cancer, but the status of <it>Bmi-1 </it>amplification and expression in ovarian cancer and its clinical/prognostic significance are unclear.</p> <p>Methods</p> <p>The methods of immunohistochemistry and fluorescence <it>in situ </it>hybridization were utilized to examine protein expression and amplification of <it>Bmi-1 </it>in 30 normal ovaries, 30 ovarian cystadenomas, 40 borderline ovarian tumors and 179 ovarian carcinomas.</p> <p>Results</p> <p>Intensive expression of Bmi-1 was detected in none of the normal ovaries, 3% cystadenomas, 10% borderline tumors, and 37% ovarian carcinomas, respectively. Amplification of <it>Bmi-1 </it>was detected in 8% of ovarian carcinomas. In ovarian carcinomas, significant positive associations were found between intensive expression of Bmi-1 and the tumors ascending histological grade, later pT/pN/pM and FIGO stages (<it>P </it>< 0.05). In univariate survival analysis of the ovarian carcinoma cohorts, a significant association of intensive expression of Bmi-1 with shortened patient survival (mean 49.3 months <it>versus </it>100.3 months, <it>p </it>< 0.001) was demonstrated. Importantly, Bmi-1 expression provided significant independent prognostic parameters in multivariate analysis (<it>p </it>= 0.005).</p> <p>Conclusions</p> <p>These findings provide evidence that intensive expression of Bmi-1 might be important in the acquisition of an invasive and/or aggressive phenotype of ovarian carcinoma, and serve as a independent biomarker for shortened survival time of patients.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.